sae reporting in clinical trials (academic and sponsored)
Published 2 years ago • 1.1K plays • Length 31:24Download video MP4
Download video MP3
Similar videos
-
19:44
baseline assessment in clinical trial
-
14:03
who is a healthy subject in a clinical trial
-
16:05
chapter 3. new drugs and cosmetic act, 2019
-
9:57
post marketing assessment. new drugs and ct rules, 2019
-
48:21
webinar — ethnobridging in phase i clinical trials
-
12:49
third schedule. new drugs and ct rules, 2019
-
57:35
drug labeling studies in clinical pharmacology: recent fda/ema updates
-
![[webinar] ich e9(r1) addendum on estimands and sensitivity analysis](https://i.ytimg.com/vi/CdT_EbwPNFA/mqdefault.jpg)
40:18
[webinar] ich e9(r1) addendum on estimands and sensitivity analysis
-
1:00:07
2 pharmaceuticalstatistics clinical trial introduction part2
-
21:28
case discussion || adrenal insufficiency
-
46:02
itc5 2021 dr. antoine lentacker: how to report a side effect? web-based pharmacovigilance.
-
52:06
bioassays 2020 keynote: steven kozlowski, cder, fda
-
3:31
the decaaf ii randomized clinical trial
-
1:57:05
joint webinar on estimands in clinical trials (nov 5, 2020)
-
1:57
aes and saes in clinical research in under 2 minutes
-
48:32
de-risk your program with evidence-based secondary pharmacology insights
-
39:07
faqs.new drugs and ct rules, 2019
-
20:03
oncology. recist 1.1
-
8:01
polypill
-
0:21
sisaqol imi | glossary term: randomised clinical trial